Cargando…
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
Vascular endothelial growth factor (VEGF)-A-driven angiogenesis contributes to various disorders including cancer and proliferative diabetic retinopathy (PDR). Among several VEGF-A blockers clinically used is aflibercept, a chimeric VEGFR1/VEGFR2-based decoy receptor fused to the Fc fragment of IgG1...
Autores principales: | Kanda, Atsuhiro, Noda, Kousuke, Saito, Wataru, Ishida, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673700/ https://www.ncbi.nlm.nih.gov/pubmed/26648523 http://dx.doi.org/10.1038/srep17946 |
Ejemplares similares
-
Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy
por: Kanda, Atsuhiro, et al.
Publicado: (2017) -
Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy
por: Hase, Keitaro, et al.
Publicado: (2017) -
Glucocorticoid receptor inhibits Müller glial galectin‐1 expression via DUSP1‐dependent and ‐independent deactivation of AP‐1 signalling
por: Hirose, Ikuyo, et al.
Publicado: (2019) -
Glucocorticoid‐transactivated TSC22D3 attenuates hypoxia‐ and diabetes‐induced Müller glial galectin‐1 expression via HIF‐1α destabilization
por: Kanda, Atsuhiro, et al.
Publicado: (2020) -
Pathologic Roles of Receptor-Associated Prorenin System in Idiopathic Epiretinal Membrane
por: Dong, Yoko, et al.
Publicado: (2017)